Advertisement

Topics

Companies Related to "Elevated expression TIGIT cells correlates with disease activity" [Most Relevant Company Matches] RSS

03:16 EST 17th December 2018 | BioPortfolio

Here are the most relevant search results for "Elevated expression TIGIT cells correlates with disease activity" found in our extensive corporate database of over 50,000 company records.

Showing "Elevated expression TIGIT cells correlates with disease activity" Companies 1–25 of 3,700+

Relevant

Allegro Diagnostics Corp.

Allegro Diagnostics’ molecular testing platform utilizes gene expression of normal epithelial cells in the respiratory tract to detect early signs of lung cancer and diseases of the airway. The “field of injury” principle on which the platform is based refers to the detectable molecular changes that occur throughout the respiratory tract in ...


High Throughput Genomics, Inc

High Throughput Genomics (HTG) was founded to: Develop and market ArrayPlate measurement of gene expression, DNA and proteins. Develop and market gene expression quantitative Nuclease Protection Assays (qNPA™). Satisfy unmet needs encountered at all levels of drug discovery, clinical development, and clinical practice. Other commercialized methods for drug discovery lack sensitivity and have poo...

Cell Signaling Technology, Inc.

The genomic era has yielded a wealth of new genes for which function and inter-relationships remain unknown. At the same time there is an increasing appreciation of the limits of what can be learned from gene expression profiling, and of the need to examine protein expression and activity. Activation-state-specific antibodies have proven to be a convenient and reliable set of tools in the new post...


Memgen, LLC

Memgen is a clinical-stage biotechnology company developing immunotherapies to improve survival and quality of life of patients with cancer, autoimmune conditions and infectious diseases. Memgen’s patent-protected, re-engineered molecules, which are based on the tumor necrosis factor (TNF) superfamily of molecules, target specific receptors express...

Immunicon Corporation

Immunicon is developing and commercializing diagnostic and research products for rare cell analysis and molecular research, with an initial focus on cancer. Our instruments and reagents are used to capture, count and characterize rare cells including circulating tumor cells (CTCs) in cancer patients or circulating endothelial cells (CECs), which are elevated in a variety of diseases. Our goal is t...

Myeloma Canada

Multiple myeloma, a cancer of the bone marrow, is an incurable but treatable disease. The cancer starts in plasma cells, which are produced in the bone marrow. In myeloma, abnormal plasma cells, called myeloma cells, grow uncontrollably, crowding out the normal blood cells in the bone. This can bring on symptoms such as fatigue, recurrent infections and se...

XDx, Inc.

Based in Brisbane, California, XDx is a molecular diagnostics company focused on the discovery, development and commercialization of noninvasive gene expression-based tests for the monitoring of transplant rejection and autoimmune diseases. The company has developed a proprietary new method for noninvasively monitoring immune system activity by measuring g...

Diacrin Incorporated

Diacrin is developing transplantable cells for the treatment of human diseases which are characterized by cell dysfunction or cell death and for which current therapies are either inadequate or nonexistent. Products under development for the treatment of neurological disorders include: NeuroCell(TM)-PD for Parkinson's disease and NeuroCell(TM)-HD for Huntington's dise...

ExcellGene SA

ExcellGene is a successful commercial spin-off from the laboratory of Dr. Wurm, Professor of Biotechnology at the Swiss Federal Institute of Technology in Lausanne (EPFL). Since it's founding in 2003, it has moved into new laboratories in Monthey, Valais, Switzerland, approximately 60 km from Lausanne.ExcellGene is an internationally recognized company with leading expertise in rapid process devel...

Vivomicx

We identify: real biomarkers for drug efficacy to speed up your development process Using this, you can relate true molecular effects to disease activity and the value of your biomarkers We Validate: the pharmacological identity of your NME in complex tissues in vivo, before your drug enters clinical testing the expression of your new putative targets in patient materials your biomarkers...

TapImmune, Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’s vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patients’ killer T...

Chromos Molecular Systems Incorporated

Chromos Molecular Systems Inc. (“CHROMOS”; TSE: CHR) is a public Canadian biotechnology company leading the development of innovative therapies using a proprietary gene delivery and expression system for the production of therapeutic proteins and cell-mediated gene therapies to treat disease. Chromos is achieving this objective with a unique mammalian chromosome technology platform from which ...

GliaMed, Inc.

GliaMed is a development-stage biopharmaceutical company dedicated to the development of small molecule drugs which enhance the human body’s innate ability to regenerate. Founded in 2001, the company is focused on the development of compounds termed Regenerative Immunophilin Ligands or RILs. In pre-clinical models, treatment with RILs has been shown to ...

Kinex Pharmaceuticals, LLC

Kinex Pharmaceuticals is developing next generation anti-cancer drugs that target the molecular basis of disease. The Company uses a proprietary technology platform to generate compounds that inhibit the Protein Kinase and Phosphatase family of proteins.Protein kinases and phosphatases are families of proteins that are intimately involved in transmitting signals across the cell membrane. They cont...

4SC AG

4SC AG (ISIN DE0005753818) is a drug discovery and development company focused on autoimmune and cancer indications. Vidofludimus (4SC-101), a small molecule, is currently in a Phase IIb study in rheumatoid arthritis and a Phase IIa exploratory study in inflammatory bowel disease. The company's lead oncology compound, resminostat (4SC-201), a pan histone d...

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutical companies and are now marketing commercial products based upon our world-beating flashBAC protein expression technologyOET was founded in 2000 by leading members of the School of Biological and Mol...

Genespan Corporation

Genespan Corporation has developed a platform technology for maintaining the expression and achieving regulation of normal and foreign genes in cultured cells and in vivo. The resulting multi-faceted platform technology has enabled Genespan's experienced management team to position the Company for growth. It is poised to become the world leader in developing novel products for the expanding market...

rPeptide, LLC

rPeptide is a biotechnology company located in Athens, Georgia, USA, and is a market leader in providing research products (recombinant peptides and proteins, antibodies, reagents) for Alzheimer's disease and Parkinson's disease research. rPeptide also provides a range of custom services from molecular biology, protein expression and purification, to 13C and 15N uniform labeling of peptides and pr...

Brainstorm Cell Therapeutics

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) and Multiple Sclerosis (MS). The adu...

Solace Pharmaceuticals

Solace Pharmaceuticals discovers and develops innovative treatments for pain. Solace's research and development programs are focused on exploiting novel biological understanding of disease targets that play a role in the pathogenesis of pain and that have disease-modifying potential in two key areas: modulating the activity of glial cells and intervening in the tetrohydrobiopterin (BH4) pathway. ...

Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has one Phase 3 clinical program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2 (sPLA...

Expression Genetics, Inc.

Expression Genetics, Inc. (EGEN), is a privately held biopharmaceutical company specializing in nucleic acid (DNA and RNAi) delivery and therapeutics aimed at specific disease targets. The Company, with laboratories and headquarters in Huntsville, Alabama, is focused on developing therapeutics for the treatment of human diseases including cancer and cardiovascular disease. The Company has a si...

Imgenex Corp

Imgenex Corp. develops and commercializes novel reagents for the scientific study of human biology and disease and for the production of new diagnostic assays and potential therapies of such diseases. These novel reagents include antibodies, gene and protein expression systems, and arrays of various cells and tissues for use in studies of functional genomics. Areas of biological interest at Imgene...

Forever Labs

Forever Labs is the first company to bank young adult stem cells, so you can live a healthier and longer life. Research on stem cells suggest that as you age, you lose stem cells and the ones that remain become damaged and less effective. As a longevity company and an educational force in stem cell research, Forever Labs is transforming the healthcare indu...

Celcuity Inc.

We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. Our proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular activity dri...


More From BioPortfolio on "Elevated expression TIGIT cells correlates with disease activity"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks